Morbid Obesity: Clinical Trials

432 trials for Morbid Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

256 completed, 85 unknown, 25 terminated, 21 recruiting. 232 Not applicable, 30 Phase 4, 19 Phase 2, 19 Phase 3, 13 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable232Completed 141, Unknown 45, Terminated 16, Recruiting 10, Active not recruiting 8, Withdrawn 7, Not yet recruiting 3, Enrolling by invitation 1, Suspended 1
Phase 430Completed 16, Not yet recruiting 6, Unknown 5, Withdrawn 2, Recruiting 1
Phase 219Completed 10, Unknown 8, Terminated 1
Phase 319Completed 10, Unknown 9
Phase 113Completed 7, Unknown 5, Withdrawn 1
Early Phase 13Completed 2, Recruiting 1

Follow this condition Literature Review of Morbid Obesity trials Research Report on Morbid Obesity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)
Semaglutide weekly injection, Placabo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1042026-10-012026-10-05
Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Prophylactic mesh - Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruitingAesculap AG1102026-09-012026-06-02
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
GLP-1 receptor agonist therapy - Morbid Obesity, Anorectal Diseases
Not yet recruitingGazi University1002026-08-012026-06-25
Impact of Bariatric Surgery on Female Sexual Function and Sex Hormones
Sleeve Gastrectomy, Gastric Bypass - Morbid Obesity
RecruitingCairo University402026-06-052026-06-10
Investigation of the Effects of Whole Body Vibration Application on Muscle Functional Level, Physical Fitness and Respiratory Parameters After Bariatric Surgery
Resistance Training, Whole Body Vibration, Control Group - Obesity & Overweight, Morbid Obesity
Not applicableNot yet recruitingKirsehir Ahi Evran Universitesi602026-05-302026-05-22
Bedside Lung Ultrasound to Monitor Lung Recruitment in Obese Patients
Morbid Obesity, Obesity
Not yet recruitingAssiut University452026-05-012026-04-21
Interaction Between Head/Neck Position and C-MAC Blade Geometry on Videolaryngoscopic Intubation in Morbidly Obese Patients: A Randomized Controlled Trial
Sniffing position and using MAC blade., Ramped position and MAC Blade, videolaryngoscopy - Morbid Obesity
Not applicableActive not recruitingAin Shams University1402026-04-172026-06-09
Stool Analysis After Sleeve Gastrectomy vs Gastric Bypass
Laparoscopic Sleeve Gastrectomy, Mini Gastric Bypass, Roux-en-Y Gastric Bypass - Morbid Obesity
RecruitingCairo University502026-04-052026-05-18
Cost-Effectiveness and Outcome of Robot-assisted Vs Laparoscopic Roux-en-Y Gastric Bypass
Laparoscopic and robotic (DaVinci) RYGB - Morbid Obesity
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS5122026-01-012025-09-04
Impact of Reverse Trendelenburg on ONSD in Obesity Surgery
Pre-pneumoperitoneum Reverse Trendelenburg Group - Morbid Obesity
Not applicableCompletedBagcilar Training and Research Hospital902026-01-012026-07-14
Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients
Standard Post-Bariatric Care (Control), Early Time-Restricted Eating (eTRE), Chronotype-Based Chrono-Nutrition (CB-CN) - Obesity (Disorder), Morbid Obesity
Not applicableNot yet recruitingKing Saud University2462026-01-012026-01-07
Ketodex Versus Opioid Based Anesthesia in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy.
ketamine and dexmeditomidine combination, Fentanyl (IV) - Morbid Obesity
Not applicableActive not recruitingCairo University82025-11-112026-04-08
Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort Study
Gastroesophageal Reflux Disease, Morbid Obesity
Enrolling by invitationClinica Gastrobese752025-09-172025-09-25
EOIB for Laparoscopic Sleeve Gastrectomy
Bilateral ultrasound guided external oblique intercostal block (EOIB), ıv morphine PCA - Acute Pain, Regional Anesthesia
CompletedOndokuz Mayıs University202025-08-012025-12-23
The Effect of Cognitive Function Level in Morbidly Obese Patients
Obesity, Morbid Obesity
Not yet recruitingKocaeli City Hospital772025-07-222025-06-29
Efficacy of Nebulized Dexmedetomidine on Blunting Hemodynamic Changes During Intubation and Pneumoperitoneum in Morbid Obese Patients During Laparoscopic Bariatric Surgery
Dexmedetomidine, Normal Saline - Nebulization, Dexmedetomidine
Not applicableCompletedTanta University902025-07-102025-12-23

Showing 20 of 432. Sign in to see all of them.

Narrower conditions

Obesity, Morbid (432)  ·  Obesity (104)  ·  Weight Loss (39)  ·  Metabolic Syndrome (21)  ·  Diabetes Mellitus (16)  ·  Motor Activity (13)  ·  Insulin Resistance (12)  ·  Non-alcoholic Fatty Liver Disease (11)  ·  Gastroesophageal Reflux (10)  ·  Hypertension (10)  ·  Diabetes Mellitus, Type 2 (9)  ·  Postoperative Complications (8)  ·  Fatty Liver (6)  ·  Pain, Postoperative (6)  ·  Sleep Apnea, Obstructive (6)

Broader conditions

Nutrition Disorders (432)  ·  Nutritional and Metabolic Diseases (432)  ·  Overnutrition (432)  ·  Pathological Conditions, Signs and Symptoms (432)  ·  Signs and Symptoms (432)  ·  Body Weight (430)  ·  Overweight (429)  ·  Obesity (328)  ·  Glucose Metabolism Disorders (50)  ·  Metabolic Diseases (50)  ·  Body Weight Changes (44)  ·  Digestive System Diseases (39)  ·  Pathologic Processes (39)  ·  Hyperinsulinism (29)  ·  Endocrine System Diseases (27)

Interventions

Gastric Bypass (27)  ·  Bariatric Surgery (26)  ·  Exercise (6)  ·  Ketamine (5)  ·  Acetaminophen (4)  ·  Fentanyl (4)  ·  Saline Solution (4)  ·  Bupivacaine (3)  ·  Caloric Restriction (3)  ·  Dexmedetomidine (3)  ·  Diet (3)  ·  Lidocaine (3)  ·  Propofol (3)  ·  Rocuronium (3)  ·  Sugammadex (3)

Sponsors

Mansoura University (13)  ·  Rijnstate Hospital (10)  ·  IHU Strasbourg (9)  ·  Assistance Publique - Hôpitaux de Paris (6)  ·  General Committee of Teaching Hospitals and Institutes, Egypt (6)  ·  Inonu University (6)  ·  Istanbul University (6)  ·  Minia University (6)  ·  Ain Shams University (5)  ·  Ethicon Endo-Surgery (5)  ·  Hospital Universitari de Bellvitge (5)  ·  University of Alberta (5)  ·  University of Patras (5)  ·  Cairo University (4)  ·  Catholic University of the Sacred Heart (4)

Countries

United States (109)  ·  Egypt (43)  ·  France (33)  ·  Spain (23)  ·  Turkey (Türkiye) (23)  ·  Italy (21)  ·  Netherlands (21)  ·  Canada (15)  ·  Israel (15)  ·  Brazil (14)  ·  Norway (10)  ·  Greece (9)  ·  Germany (8)  ·  Chile (6)  ·  United Kingdom (6)

Top investigators

John P Cello, MD (4)  ·  Andrei Keidar, MD (3)  ·  Sameh H Emile, M.D. (3)  ·  Alaa M Sewefy, MD (2)  ·  Alexandros Kokkinos, MD, PhD (2)  ·  F.J. Berends, MD, PhD (2)  ·  Geltrude Mingrone, MD (2)  ·  Gerhard Prager, M.D. (2)  ·  Jonathan T Carter, MD (2)  ·  Michel Vix, MD (2)  ·  Michele Carron, MD (2)  ·  Miguel J Garcia-Oria, MD PhD FACS (2)  ·  Ninh T Nguyen, MD (2)  ·  Santiago Horgan, MD (2)

Results publications

PMID 20010088, PMID 22963820, PMID 24527718, PMID 30247434, PMID 37652841, PMID 38055284, PMID 39819027, PMID 40854969, PMID 41077621, PMID 10592173, PMID 10604470, PMID 11435250, PMID 11472277, PMID 11549535, PMID 11687509, PMID 11733397, PMID 11867408, PMID 12194550, PMID 12456460, PMID 12540590, PMID 14674978, PMID 14750005, PMID 15105237, PMID 15502875, PMID 15864338, PMID 15946441, PMID 15978146, PMID 16076986, PMID 16235331, PMID 16259892, PMID 16271160, PMID 16778582, PMID 17128540, PMID 17253531, PMID 17360978, PMID 17728530, PMID 17885457, PMID 17894144, PMID 18040751, PMID 18193178, PMID 18308313, PMID 18387434, PMID 19403595, PMID 19587363, PMID 19638921, PMID 19641201, PMID 19689793, PMID 19730234, PMID 19926983, PMID 20124732

NIH funding

2009 (2), 2014 (1), R01DK067561 (1), R01DK072526 (1), R01DK107629 (1), R01DK126721 (1), R21DK129893 (1), U01DK066557 (1)